GeneDx Holdings (WGS) Total Current Liabilities (2020 - 2026)

GeneDx Holdings has disclosed Total Current Liabilities across 7 years of filings, most recently posting $87.6 million for Q1 2026.

• In Q1 2026, Total Current Liabilities rose 26.02% year-over-year to $87.6 million; the TTM figure through Mar 2026 stood at $87.6 million (up 26.02% YoY), while the FY2025 annual figure was $108.9 million, up 98.68% from the prior year.
• Total Current Liabilities slipped to $87.6 million in Q1 2026, from $108.9 million in the prior quarter.
• Over the last five years, Total Current Liabilities for WGS reached as high as $204.6 million in Q2 2022 and fell as low as $50.7 million in Q1 2024.
• The 5-year median for Total Current Liabilities is $84.4 million (2023), against an average of $95.2 million.
• Annual changes were most pronounced in 2022 — Total Current Liabilities jumped 181.77% — and 2023, when it slumped 59.24%.
• A 5-year view of Total Current Liabilities shows it stood at $144.3 million in 2022, then tumbled by 59.24% to $58.8 million in 2023, then fell by 6.8% to $54.8 million in 2024, then surged by 98.68% to $108.9 million in 2025, then fell by 19.53% to $87.6 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $87.6 million, $108.9 million, and $87.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.